AtriCure

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AtriCure and other ETFs, options, and stocks.

About ATRC

AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. 

CEO
Michael H. Carrel
CEOMichael H. Carrel
Employees
1,350
Employees1,350
Headquarters
Mason, Ohio
HeadquartersMason, Ohio
Founded
1994
Founded1994
Employees
1,350
Employees1,350

ATRC Key Statistics

Market cap
1.45B
Market cap1.45B
Price-Earnings ratio
-120.62
Price-Earnings ratio-120.62
Dividend yield
Dividend yield
Average volume
500.55K
Average volume500.55K
High today
$29.09
High today$29.09
Low today
$27.31
Low today$27.31
Open price
$27.84
Open price$27.84
Volume
507.83K
Volume507.83K
52 Week high
$43.18
52 Week high$43.18
52 Week low
$27.31
52 Week low$27.31

Stock Snapshot

The current AtriCure(ATRC) stock price is $29.07, with a market capitalization of 1.45B. The stock trades at a price-to-earnings (P/E) ratio of -120.62.

During the trading session on 2026-04-04, AtriCure(ATRC) shares reached a daily high of $29.09 and a low of $27.31. At a current price of $29.07, the stock is +6.4% higher than the low and still -0.1% under the high.

Trading activity shows a volume of 507.83K, compared to an average daily volume of 500.55K.

The stock's 52-week range extends from a low of $27.31 to a high of $43.18.

The stock's 52-week range extends from a low of $27.31 to a high of $43.18.

ATRC News

Simply Wall St 2h
Should AtriCure’s Q4 Revenue Beat and Cautious Analyst Tone Reshape the ATRC Investment Narrative?

AtriCure recently reported its fourth-quarter 2025 results, highlighting 15% revenue growth that underscored continued demand for its cardiac and pain managemen...

Should AtriCure’s Q4 Revenue Beat and Cautious Analyst Tone Reshape the ATRC Investment Narrative?

Analyst ratings

78%

of 9 ratings
Buy
77.8%
Hold
22.2%
Sell
0%

People also own

Based on the portfolios of people who own ATRC. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.